CLAUSES DE NON-RESPONSABILITÉ
MiYOSMART n’a pas été approuvé pour la prise en charge de lamyopie dans tous les pays, y compris les États-Unis, et n’est actuellement pas disponible à la vente dans tous les pays, y compris les États-Unis.
Les verres MiYOSMART peuvent ne pas être en mesure de traiter les conditions des personnes en raison de déficiences naturelles, de maladies, de conditions médicales préexistantes et/ou d’âge avancé des consommateurs. Les renseignements contenus dans les documents présents sont des renseignements généraux et ne sont pas destinés à constituer des conseils médicaux.
Cette brochure contient des recommandations destinées aux professionnels de la vue. Il incombe à ceux-ci de s’assurer que l’utilisation de la procédure recommandée est autorisée dans le pays où ils exercent.L’adéquation de chaque procédure recommandée pour le patient doit être évaluée par le professionnel de la vue sur la base de son jugement professionnel personnel.
Références:
References:
1. Ho CL, Wu WF, Liou YM. Dose-Response Relationship of Outdoor Exposure and Myopia Indicators: A Systematic Review and Meta-Analysis of Various Research Methods. Int J Environ Res Public Health. 2019;16(14):2595.
2. HOYA data on file. Harris Interactive: HOYA Vision Care concept testing – MiYOSMART Sun. 07/2022.
3. Jonas JB, Ang M, Cho P, et al. IMI prevention of myopia and its progression. Invest Ophthalmol Vis Sci. 2021;62(5):6.
4. WSPOS. Myopia Survey Data. November 2022. Presented as part of WSPOS Symposium: Comprehensive Update on Myopia Management.19-20 November 2022. Available from: http://forum.wspos.org/symposium-part-1-comprehensive-update-on-myopia-management-2 (Last accessed: 20/02/2023).
5. WSPOS. Sunlight Exposure & Children’s Eyes Consensus Statement. 2016. Available at: https://www.wspos.org/wspos-sunlight-exposure-childrens-eyes-consensus-statement/(Last accessed 20/02/2023).
6. Prevent Blindness. Children’s Eyes are More Susceptible to Long-Term Damage from UV Rays. 2011. Available at: https://preventblindness.org/childrens-eyes-are-more-susceptible-tolong-term-damage-from-uv-rays/ (Last accessed 20/02/2023).
7. Artigas JM, Felipe A, Navea A, Fandiño A, Artigas C. Spectral transmission of the human crystalline lens in adult and elderly persons: color and total transmission of visible light. Invest Ophthalmol Vis Sci. 2012;53(7):4076-4084.
8. Li FF, Yam JC. Low-Concentration Atropine Eye Drops for Myopia Progression. Asia Pac J Ophthalmol (Phila). 2019;8(5):360-365.
9. Gong Q, Janowski M, Luo M, et al. Efficacy and Adverse Effects of Atropine in Childhood Myopia: A Meta-analysis. JAMA Ophthalmol. 2017;135(6):624-630.
10. Wu PC, Chuang MN, Choi J, et al. Update in myopia and treatment strategy of atropine use in myopia control. Eye (Lond). 2019;33(1):3-13.
11. HOYA data on file. Transmission, traffic light recognition, and UV blocking test for MiYOSMART clear and polarized lenses. 02/2023.Tests were conducted at room temperature (23°C).
12. HOYA data on file. PSF test on MiYOSMART clear and sun spectacle lenses. 06/2022.
13. HOYA data on file. Lens performance validation test for MiYOSMART photochromic lenses – activation and deactivation. 02/2023. Tests were conducted at room temperature (23°C).
14. HOYA data on file. Transmission, traffic light recognition, and UV blocking test for MiYOSMART clear and photochromic lenses. 02/2023. Tests were conducted at room temperature (23°C).
15. Lakkis C, Weidemann K. Evaluation of the performance of photochromic spectacle lenses in children and adolescents aged 10 to 15 years. Clin Exp Optom. 2006;89(4):246-252.
16. Renzi-Hammond LM, Hammond BR Jr. The effects of photochromic lenses on visual performance. Clin Exp Optom. 2016;99(6):568-574.
17. Wu PC, Kuo HK. Effect of photochromic spectacles on visual symptoms and contrast sensitivity of myopic schoolchildren treated with low dose concentration atropine. Invest Ophthalmol Vis Sci. 2016;57:2484.
18. Quintana MS, Langa A, del Moral-Martinez I, et al. Polarized Filters Enhance Contrast Sensitivity When Glare Is Produced On A Flat Surface Under Photopic Conditions. Invest Ophthalmol Vis S ci. 2006;47(13):1225
19. Lam CSY, Tang WC, Tse DY, et al. Defocus Incorporated Multiple Segments (DIMS) spectacle lenses slow myopia progression: a 2-year randomised clinical trial. Br J Ophthalmol. 2020;104(3):363-368.